Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Jul;65(7):2868–2875. doi: 10.1128/iai.65.7.2868-2875.1997

Analysis of toxicity of streptococcal pyrogenic exotoxin A mutants.

M Roggiani 1, J A Stoehr 1, B A Leonard 1, P M Schlievert 1
PMCID: PMC175403  PMID: 9199461

Abstract

Streptococcal pyrogenic exotoxin A (SPE A) is secreted by some strains of Streptococcus pyogenes and is strongly associated with streptococcal toxic shock syndrome (STSS), a severe and often fatal illness. SPE A possesses a number of biological properties, some of which are shared with a group of exotoxins of streptococcal and staphylococcal origins, the pyrogenic toxin superantigens (PTSAgs). SPE A's most extensively studied property is superantigenicity. Superantigenic activation of T cells and monocytes stimulates the release of cytokines such as tumor necrosis factors alpha and beta, interleukin 1, and gamma interferon. These endogenous mediators are considered to be the primary cause of capillary leak, hypotension, and shock, the most severe manifestations of STSS. However, several studies have suggested that other properties of SPE A, such as ability to greatly enhance host susceptibility to endotoxin and ability to interact directly with endothelial cells, may play substantial roles in the syndrome. In this work we generated single- and double-site mutations of SPE A at residues K16, N20, C87, C90, C98, K157, S195, N20/C98, and N20/K157. The mutant SPE A's were analyzed in vivo for their lethal activity and in vitro for their superantigenic ability. Our results indicate that SPE A's ability to induce lethality and endotoxin enhancement does not require superantigenicity, and conversely superantigenicity does not necessarily lead to lethality. Thus, these properties and their relative contributions to the onset of hypotension and shock may be separable. Furthermore, evidence is presented that certain mutant toxins may be suitable for use as vaccine toxoids.

Full Text

The Full Text of this article is available as a PDF (505.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barsumian E. L., Schlievert P. M., Watson D. W. Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins. Infect Immun. 1978 Dec;22(3):681–688. doi: 10.1128/iai.22.3.681-688.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bohach G. A., Fast D. J., Nelson R. D., Schlievert P. M. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol. 1990;17(4):251–272. doi: 10.3109/10408419009105728. [DOI] [PubMed] [Google Scholar]
  3. Chang S., Cohen S. N. High frequency transformation of Bacillus subtilis protoplasts by plasmid DNA. Mol Gen Genet. 1979 Jan 5;168(1):111–115. doi: 10.1007/BF00267940. [DOI] [PubMed] [Google Scholar]
  4. Clark J. M. Novel non-templated nucleotide addition reactions catalyzed by procaryotic and eucaryotic DNA polymerases. Nucleic Acids Res. 1988 Oct 25;16(20):9677–9686. doi: 10.1093/nar/16.20.9677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA. 1993 Jan 20;269(3):390–391. [PubMed] [Google Scholar]
  6. Deringer J. R., Ely R. J., Stauffacher C. V., Bohach G. A. Subtype-specific interactions of type C staphylococcal enterotoxins with the T-cell receptor. Mol Microbiol. 1996 Nov;22(3):523–534. doi: 10.1046/j.1365-2958.1996.1381506.x. [DOI] [PubMed] [Google Scholar]
  7. Fields B. A., Malchiodi E. L., Li H., Ysern X., Stauffacher C. V., Schlievert P. M., Karjalainen K., Mariuzza R. A. Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature. 1996 Nov 14;384(6605):188–192. doi: 10.1038/384188a0. [DOI] [PubMed] [Google Scholar]
  8. Grossman D., Van M., Mollick J. A., Highlander S. K., Rich R. R. Mutation of the disulfide loop in staphylococcal enterotoxin A. Consequences for T cell recognition. J Immunol. 1991 Nov 15;147(10):3274–3281. [PubMed] [Google Scholar]
  9. Harris T. O., Betley M. J. Biological activities of staphylococcal enterotoxin type A mutants with N-terminal substitutions. Infect Immun. 1995 Jun;63(6):2133–2140. doi: 10.1128/iai.63.6.2133-2140.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Harris T. O., Grossman D., Kappler J. W., Marrack P., Rich R. R., Betley M. J. Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins. Infect Immun. 1993 Aug;61(8):3175–3183. doi: 10.1128/iai.61.8.3175-3183.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hauser A. R., Stevens D. L., Kaplan E. L., Schlievert P. M. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol. 1991 Aug;29(8):1562–1567. doi: 10.1128/jcm.29.8.1562-1567.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hemsley A., Arnheim N., Toney M. D., Cortopassi G., Galas D. J. A simple method for site-directed mutagenesis using the polymerase chain reaction. Nucleic Acids Res. 1989 Aug 25;17(16):6545–6551. doi: 10.1093/nar/17.16.6545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hoffmann M. L., Jablonski L. M., Crum K. K., Hackett S. P., Chi Y. I., Stauffacher C. V., Stevens D. L., Bohach G. A. Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1. Infect Immun. 1994 Aug;62(8):3396–3407. doi: 10.1128/iai.62.8.3396-3407.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hovde C. J., Marr J. C., Hoffmann M. L., Hackett S. P., Chi Y. I., Crum K. K., Stevens D. L., Stauffacher C. V., Bohach G. A. Investigation of the role of the disulphide bond in the activity and structure of staphylococcal enterotoxin C1. Mol Microbiol. 1994 Sep;13(5):897–909. doi: 10.1111/j.1365-2958.1994.tb00481.x. [DOI] [PubMed] [Google Scholar]
  15. Hsiao K. A fast and simple procedure for sequencing double stranded DNA with sequenase. Nucleic Acids Res. 1991 May 25;19(10):2787–2787. doi: 10.1093/nar/19.10.2787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Johnson L. P., Schlievert P. M. Group A streptococcal phage T12 carries the structural gene for pyrogenic exotoxin type A. Mol Gen Genet. 1984;194(1-2):52–56. doi: 10.1007/BF00383496. [DOI] [PubMed] [Google Scholar]
  17. Kappler J. W., Herman A., Clements J., Marrack P. Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J Exp Med. 1992 Feb 1;175(2):387–396. doi: 10.1084/jem.175.2.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kline J. B., Collins C. M. Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A. Infect Immun. 1996 Mar;64(3):861–869. doi: 10.1128/iai.64.3.861-869.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kushnaryov V. M., MacDonald H. S., Reiser R. F., Bergdoll M. S. Reaction of toxic shock syndrome toxin 1 with endothelium of human umbilical cord vein. Rev Infect Dis. 1989 Jan-Feb;11 (Suppl 1):S282–S288. doi: 10.1093/clinids/11.supplement_1.s282. [DOI] [PubMed] [Google Scholar]
  20. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  21. Lee P. K., Deringer J. R., Kreiswirth B. N., Novick R. P., Schlievert P. M. Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins. Infect Immun. 1991 Mar;59(3):879–884. doi: 10.1128/iai.59.3.879-884.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lee P. K., Vercellotti G. M., Deringer J. R., Schlievert P. M. Effects of staphylococcal toxic shock syndrome toxin 1 on aortic endothelial cells. J Infect Dis. 1991 Oct;164(4):711–719. doi: 10.1093/infdis/164.4.711. [DOI] [PubMed] [Google Scholar]
  23. Leonard B. A., Schlievert P. M. Immune cell lethality induced by streptococcal pyrogenic exotoxin A and endotoxin. Infect Immun. 1992 Sep;60(9):3747–3755. doi: 10.1128/iai.60.9.3747-3755.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Malchiodi E. L., Eisenstein E., Fields B. A., Ohlendorf D. H., Schlievert P. M., Karjalainen K., Mariuzza R. A. Superantigen binding to a T cell receptor beta chain of known three-dimensional structure. J Exp Med. 1995 Dec 1;182(6):1833–1845. doi: 10.1084/jem.182.6.1833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Marrack P., Kappler J. The staphylococcal enterotoxins and their relatives. Science. 1990 May 11;248(4956):705–711. doi: 10.1126/science.2185544. [DOI] [PubMed] [Google Scholar]
  26. Murray D. L., Earhart C. A., Mitchell D. T., Ohlendorf D. H., Novick R. P., Schlievert P. M. Localization of biologically important regions on toxic shock syndrome toxin 1. Infect Immun. 1996 Jan;64(1):371–374. doi: 10.1128/iai.64.1.371-374.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Murray D. L., Prasad G. S., Earhart C. A., Leonard B. A., Kreiswirth B. N., Novick R. P., Ohlendorf D. H., Schlievert P. M. Immunobiologic and biochemical properties of mutants of toxic shock syndrome toxin-1. J Immunol. 1994 Jan 1;152(1):87–95. [PubMed] [Google Scholar]
  28. Musser J. M., Hauser A. R., Kim M. H., Schlievert P. M., Nelson K., Selander R. K. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2668–2672. doi: 10.1073/pnas.88.7.2668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Norrby-Teglund A., Norgren M., Holm S. E., Andersson U., Andersson J. Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B. Infect Immun. 1994 Sep;62(9):3731–3738. doi: 10.1128/iai.62.9.3731-3738.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Parsonnet J., Gillis Z. A., Richter A. G., Pier G. B. A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1. Infect Immun. 1987 May;55(5):1070–1076. doi: 10.1128/iai.55.5.1070-1076.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Perrin S., Gilliland G. Site-specific mutagenesis using asymmetric polymerase chain reaction and a single mutant primer. Nucleic Acids Res. 1990 Dec 25;18(24):7433–7438. doi: 10.1093/nar/18.24.7433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Prasad G. S., Earhart C. A., Murray D. L., Novick R. P., Schlievert P. M., Ohlendorf D. H. Structure of toxic shock syndrome toxin 1. Biochemistry. 1993 Dec 21;32(50):13761–13766. doi: 10.1021/bi00213a001. [DOI] [PubMed] [Google Scholar]
  33. SCHWAB J. H., WATSON D. W., CROMARTIE W. J. Further studies of group A streptococcal factors with lethal and cardiotoxic properties. J Infect Dis. 1955 Jan-Feb;96(1):14–18. doi: 10.1093/infdis/96.1.14. [DOI] [PubMed] [Google Scholar]
  34. SCHWAB J. H., WATSON D. W., CROMARTIE W. J. Production of generalized Shwartzman reaction with group A streptococcal factors. Proc Soc Exp Biol Med. 1953 Apr;82(4):754–761. doi: 10.3181/00379727-82-20237. [DOI] [PubMed] [Google Scholar]
  35. Schad E. M., Zaitseva I., Zaitsev V. N., Dohlsten M., Kalland T., Schlievert P. M., Ohlendorf D. H., Svensson L. A. Crystal structure of the superantigen staphylococcal enterotoxin type A. EMBO J. 1995 Jul 17;14(14):3292–3301. doi: 10.1002/j.1460-2075.1995.tb07336.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Scherer M. T., Ignatowicz L., Winslow G. M., Kappler J. W., Marrack P. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu Rev Cell Biol. 1993;9:101–128. doi: 10.1146/annurev.cb.09.110193.000533. [DOI] [PubMed] [Google Scholar]
  37. Schlievert P. M., Assimacopoulos A. P., Cleary P. P. Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis. J Lab Clin Med. 1996 Jan;127(1):13–22. doi: 10.1016/s0022-2143(96)90161-4. [DOI] [PubMed] [Google Scholar]
  38. Schlievert P. M., Bettin K. M., Watson D. W. Inhibition of ribonucleic acid synthesis by group A streptococcal pyrogenic exotoxin. Infect Immun. 1980 Feb;27(2):542–548. doi: 10.1128/iai.27.2.542-548.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Schlievert P. M., Shands K. N., Dan B. B., Schmid G. P., Nishimura R. D. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis. 1981 Apr;143(4):509–516. doi: 10.1093/infdis/143.4.509. [DOI] [PubMed] [Google Scholar]
  40. Swaminathan S., Furey W., Pletcher J., Sax M. Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature. 1992 Oct 29;359(6398):801–806. doi: 10.1038/359801a0. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES